Background Excess alcohol (ethanol, EtOH) consumption is a significant cause of chronic
liver disease, accounting for nearly half of the cirrhosis‐associated deaths in the United …

Introduction Excessive alcohol consumption leads to a myriad of detrimental health effects,
including alcohol-associated liver disease (ALD). Unfortunately, no available treatments …

Increasing evidence has demonstrated that dihydromyricetin (DMY) contains highly effective
antioxidative, anti-inflammatory, anti-microbial and anti-diabetic properties. Nevertheless …

Alcoholic liver disease (ALD), due to the multifactorial damage associated with alcohol
(ethanol) consumption and metabolism, is one of the most prevalent liver diseases in the …

Recent studies demonstrated that dihydromyricetin (DHM) has prominent therapeutic effects
on liver injury and liver cancer. By summarizing the current preclinical in vitro and in vivo …

Aims We previously reported that Hovenia dulcis Thunb. extract, a traditional Chinese
medicine rich in dihydromyricetin (DHM), exhibited a significant hepatoprotective effect …

Aims Dihydromyricetin (DMY), a flavonoid component isolated from Ampelopsis
grossedentata, was recently reported to ameliorate nonalcoholic fatty liver disease (NAFLD) …

Dihydromyricetin (DMY) is the most abundant flavonoid in Ampelopsis grossedentata
possessing many pharmacological activities. But less is known about its protective effect …

Aims: Our previous clinical trial indicated that the flavonoid dihydromyricetin (DHM) could
improve hepatic steatosis in patients with nonalcoholic fatty liver disease (NAFLD), altough …

This study aimed to investigate the beneficial effects of myricetin in a diet-induced
nonalcoholic steatohepatitis (NASH) model and the underlying mechanism. C57BL/6J mice …